High molecular weight hyaluronan and stroma-embedded factors of radiation-sterilized amniotic membrane stimulate proliferation of HaCaT cell line in vitro

Central-European Journal of Immunology

Volumn 36, Issue 4, 2011, Pages 205-211

  Litwiniuk, Małgorzata ^a   Bikowska, Barbara ^a   Niderla Bielińska, Justyna ^a   Jóźwiak, Jarosław ^a   Kamiński, Artur ^a   Skopiński, Piotr ^a   Grzela, Tomasz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Amniotic membrane; Cytokines; HaCaT cell line; Hyaluronan; Protein microarray

Indexed keywords

ANGIOGENIN; EPIDERMAL GROWTH FACTOR; HYALURONIC ACID; HYALURONIDASE; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN;

AMNION; ARTICLE; CELL PROLIFERATION; CHEMICAL ANALYSIS; ELECTRON BEAM; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN MICROARRAY; RADIATION STERILIZATION; SILVER STAINING; STROMA;

EID: 84855165866     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Noble PW (2002): Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21: 25-29.
2. Jiang D, Liang J, Noble PW (2007): Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23: 435-461.
3. Meller D, Pauklin M, Thomasen H, et al. (2011): Amniotic membrane transplantation in the human eye. Dtsch Arztebl Int 108: 243-248.
4. Andonovska D, Dzokic G, Spasevska L, et al. (2008): The advantages of the application of amnion membrane in the treatment of burns. Prilozi 29: 183-198.
5. Zmijewski M, Pietraszek A (2005): The application of deepfrozen and radiation-sterilized human amnion as a biological dressing to prevent prolonged air leakage in thoracic surgery. Ann Transplant 10: 17-20.
6. Muralidharan S, Gu J, Laub GW, et al. (1991): A new biological membrane for pericardial closure. J Biomed Mater Res 25: 1201-1209. (Pubitemid 21712003)
7. Tyszkiewicz JT, Uhrynowska-Tyszkiewicz IA, Kaminski A, Dziedzic-Goclawska A(1999): Amnion allografts prepared in the Central Tissue Bank inWarsaw. Ann Transplant 4: 85-90.
8. Grosicka-Macia̧g E, Kurpios-Piec D, Szumiło M, et al. (2011): Protective effect of N-acetyl-L-cysteine against maneb induced oxidative and apoptotic injury in Chinese hamster V79 cells. Food Chem Toxicol 49: 1020-1025.
9. Ikegami-Kawai M, Takahashi T (2002): Microanalysis of hyaluronan oligosaccharides by polyacrylamide gel electrophoresis and its application to assay of hyaluronidase activity. Anal Biochem 311: 157-165. (Pubitemid 35463474)
10. Saari H, Sorsa T, Konttinen YT (1990): Reactive oxygen species and hyaluronate in serum and synovial fluid in arthritis. Int J Tissue React 12: 81-89. (Pubitemid 20265929)
11. West DC, Hampson IN, Arnold F, Kumar S (1985): Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326.
12. Hascall VC, Majors AK, De La Motte CA, et al. (2004): Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta 1673: 3-12. (Pubitemid 38844790)
13. Day AJ, de la Motte CA (2005): Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol 26: 637-643. (Pubitemid 41628196)
14. Wang CT, Lin YT, Chiang BL, et al. (2006): High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14: 1237-1247.
15. Nakamura K, Yokohama S, Yoneda M, et al. (2004): High, but not low, molecular weight hyaluronan prevents T-cellmediated liver injury by reducing proinflammatory cytokines in mice. J Gastroenterol 39: 346-354. (Pubitemid 38678783)
16. Forrester JV, Balazs EA(1980): Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40: 435-446. (Pubitemid 10086557)
17. Jiang D, Liang J, Fan J, et al. (2005): Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11: 1173-1179. (Pubitemid 43093664)
18. Barrientos S, Stojadinovic O, Golinko MS, et al. (2008): Growth factors and cytokines in wound healing. Wound Repair Regen 16: 585-601.
19. Hudson LG, McCawley LJ (1998): Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc Res Tech 43: 444-455. (Pubitemid 28565791)
20. Brown GL, Nanney LB, Griffen J, et al. (1989): Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med 321: 76-79. (Pubitemid 19170395)
21. Distler O, Neidhart M, Gay RE, Gay S (2002): The molecular control of angiogenesis. Int Rev Immunol 21: 33-49. (Pubitemid 34718259)
22. Kulka M, Fukuishi N, Metcalfe DD (2009): Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily. J Leukoc Biol 86: 1217-1226.
23. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI (2003): Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4: 269-273. (Pubitemid 36322137)
24. Avdeeva SV, Chernukha MU, Shaginyan IA, et al. (2006): Human angiogenin lacks specific antimicrobial activity. Curr Microbiol 53: 477-478. (Pubitemid 44837219)
25. Edmondson SR, Thumiger SP, Werther GA, Wraight CJ (2003): Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev 24: 737-764. (Pubitemid 38067697)
26. Ghersi G, Dong H, Goldstein LA, et al. (2002): Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J Biol Chem 277: 29231-29241.
27. Providence KM, Higgins PJ (2004): PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair. J Cell Physiol 200: 297-308. (Pubitemid 38880213)
28. Providence KM, Higgins SP, Mullen A, et al. (2008): SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Arch Dermatol Res 300: 303-310.
29. Wolbank S, Hildner F, Redl H, et al. (2009): Impact of human amniotic membrane preparation on release of angiogenic factors. J Tissue Eng Regen Med 3: 651-654.